Drug survival of biologics and non-biologics in patients affected by palmoplantar psoriasis: a "real-world", mono-center experience.
Giacomo CaldarolaGennaro Marco FalcoLaura CalabreseAlessandra D'AmoreAndrea ChiricozziMarco MarianiGerardo PalmisanoClara De SimoneKetty PerisPublished in: International journal of dermatology (2023)
Our study confirms the difficulty of treating PP and shows that biologic drugs are associated with longer persistence in treatment than non-biologics in both PP's variants, not because of their higher effectiveness but because of their better safety profile.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- randomized controlled trial
- chronic kidney disease
- rheumatoid arthritis
- systematic review
- peritoneal dialysis
- prognostic factors
- emergency department
- patient reported outcomes
- copy number
- gene expression
- dna methylation
- combination therapy
- patient reported
- free survival
- genome wide